乳腺癌表达特征在局限性前列腺癌中的预后和预测价值。 - Suppr | 超能文献

Prognostic and Predictive Value of a Breast Cancer Expression Signature in Localized Prostate Cancer.

作者信息

Abida Wassim, Scher Howard I

机构信息

Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York City, New York

出版信息

JAMA Oncol. 2017 Dec 1;3(12):1673-1674. doi: 10.1001/jamaoncol.2017.0750.

DOI:10.1001/jamaoncol.2017.0750

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Prognostic and Predictive Value of a Breast Cancer Expression Signature in Localized Prostate Cancer.乳腺癌表达特征在局限性前列腺癌中的预后和预测价值。

JAMA Oncol. 2017 Dec 1;3(12):1673-1674. doi: 10.1001/jamaoncol.2017.0750.

2

A gene transcription signature associated with hormone independence in a subset of both breast and prostate cancers.一种与部分乳腺癌和前列腺癌中激素非依赖性相关的基因转录特征。

BMC Genomics. 2007 Jun 28;8:199. doi: 10.1186/1471-2164-8-199.

3

Hormone receptors in human prostate cancer.人类前列腺癌中的激素受体

Scand J Urol Nephrol Suppl. 1988;107:39-45.

4

Relative Prognostic and Predictive Value of Gene Signature and Histologic Grade in Estrogen Receptor-Positive, HER2-Negative Breast Cancer.基因特征与组织学分级在雌激素受体阳性、人表皮生长因子受体2阴性乳腺癌中的相对预后及预测价值

Clin Breast Cancer. 2016 Apr;16(2):95-100.e1. doi: 10.1016/j.clbc.2015.10.004. Epub 2015 Nov 10.

5

Androgens and estrogens stimulate ribosome biogenesis in prostate and breast cancer cells in receptor dependent manner.雄激素和雌激素以受体依赖的方式刺激前列腺癌和乳腺癌细胞的核糖体生物发生。

Gene. 2013 Aug 15;526(1):46-53. doi: 10.1016/j.gene.2013.04.018. Epub 2013 Apr 19.

6

Distinct p53 gene signatures are needed to predict prognosis and response to chemotherapy in ER-positive and ER-negative breast cancers.需要不同的 p53 基因特征来预测 ER 阳性和 ER 阴性乳腺癌的预后和对化疗的反应。

Clin Cancer Res. 2011 Apr 15;17(8):2591-601. doi: 10.1158/1078-0432.CCR-10-1045. Epub 2011 Jan 19.

7

Elevated estrogen receptor expression in human prostatic stromal cells by androgen ablation therapy.雄激素剥夺疗法使人类前列腺基质细胞中雌激素受体表达升高。

J Urol. 1996 Sep;156(3):1194-7.

8

Hormone agonists and antagonists in the treatment of hormone sensitive breast and prostate cancer.激素激动剂和拮抗剂在激素敏感性乳腺癌和前列腺癌治疗中的应用

Cancer Surv. 1986;5(3):463-86.

9

Evaluation of public cancer datasets and signatures identifies TP53 mutant signatures with robust prognostic and predictive value.对公共癌症数据集和特征的评估确定了具有强大预后和预测价值的TP53突变特征。

BMC Cancer. 2015 Mar 26;15:179. doi: 10.1186/s12885-015-1102-7.

10

Steroid hormone receptors as targets for the therapy of breast and prostate cancer--recent advances, mechanisms of resistance, and new approaches.类固醇激素受体作为乳腺癌和前列腺癌治疗的靶点——最新进展、耐药机制及新方法

J Steroid Biochem Mol Biol. 2005 Feb;93(2-5):191-200. doi: 10.1016/j.jsbmb.2004.12.002. Epub 2005 Jan 28.

引用本文的文献

1

Circulating Tumor Cell Phenotyping via High-Throughput Acoustic Separation.通过高通量声分离对循环肿瘤细胞表型进行分析。

Small. 2018 Aug;14(32):e1801131. doi: 10.1002/smll.201801131. Epub 2018 Jul 3.